Hims & Hers CEO Andrew Dudum on the future of healthcare post-COVID, growth-stage SPAC | E1181

Jason Calacanis chats with Andrew Dudum about the journey of Hims coming out of a startup studio, its innovations in telemedicine prescriptions, and going public via SPAC. They delve into the impact of COVID on telehealth adoption, potential for acquisitions and venturing into new health conditions.

Speakers

AI Chat

Unidentified

Jason Calacanis

Host • 40%

Andrew Dudum

Guest • 58%

Partners

Chapters

0:00	Start
0:48	Jason intros Andrew Dudum & they discuss Hims coming out of a startup studio, pattern recognition, issues with healthcare & more
4:46	Going public via SPAC, Hims' major innovations via telemedicine prescriptions & viagra going generic
12:18	Squarespace - Go to for a free trial, and use code TWIST for 10% off
13:49	Hims & Hers' best marketing channels, why they are in a unique position amongst public companies
17:10	Interfacing with doctors, standardizing surveys, rethinking over-the-counter medication
26:09	LinkedIn Jobs - Post your first job free
27:41	COVID's impact on telehealth's adoption, what the healthcare industry looks like post-COVID
31:20	Potential for acquiring brick & mortar health companies & getting into physical spaces, in which types of healthcare systems does Hims & Hers provide the most value?
38:02	Rippling - For an easier way to run your startup remotely visit
39:33	Next wave of conditions that Hims & Hers will venture into, the doctor's role when telemedicine takes over
44:42	How pharmacies like Walgreens look at Hims & Hers, thinking about Amazon, opening the growth market for retail investors

Transcript

Clip

Loading transcript...